About

Providing straightforward information pertaining to drugs, drug use & drug policy. The Grey Pages promotes drug-related literacy and advocates a system of viable and tolerant drug policies. This is my personal collection of commentaries, essays, tid-bits, and other such writings on everything ranging from drug use, drug policy and drug-myths, to drug-science, addiction, human behavior, and the workings of the human brain. I started this blog with a particular focus on opioids, and over the past year have found my interest gravitate toward the intriguing, ever-changing world of designer intoxicants (i.e. "research chemicals" or "designer drugs").

Friday, February 22, 2013

Interesting Reading on Ketamine & Methoxetamine Related Toxicity

The first link describes the incidence of urinary tract symptoms and renal toxicity associated with chronic ketamine use: An Abstract/Summary

Next is an interesting read on methoxetamine (or MXE, the popular RC); a letter sent to the Home Office of the UK recommending that MXE be permanently listed as a Class B drug under the UK's Misuse of Drugs Act. Below the letter itself the author describes pharmacology of the drug itself as well as some documented cases of methoxetamine-related toxicity, including cerebellar toxicity, hyper-arousal ("sympathomimetic toxicity"), and renal/urinary tract symptoms: Full Text Here

No comments:

Post a Comment